ProBioGen AG
Dr. Sascha Ramm's work experience includes serving as the Head of DSP Development I at ProBioGen AG since April 2022. Prior to this role, they worked as an R&D Scientist in DSP at ProBioGen AG from November 2019 to March 2022. Before joining ProBioGen AG, Dr. Ramm worked as a Scientific Advisor at +49 med GmbH from October 2018 to October 2019.
Dr. Sascha Ramm completed a Bachelor of Science (BS) degree in Biowissenschaften from the University of Potsdam from 2007 to 2010. From 2010 to 2013, they pursued a Master of Science (MS) degree in Biochemie und Molekularbiologie from the same university. Lastly, they obtained a Doctor of Philosophy (PhD) degree in Biochemie from Technische Universität Berlin from 2013 to 2018.
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.